loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 200169 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Hikma Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HIKMA (1)

    filter

    01 CONCENTRATE;ORAL (1)

    filter

    01 RX (1)

    filter

    01 LORAZEPAM (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    LORAZEPAM

    PDF Supplier PDF
    URL Supplier Web Content
    CONCENTRATE; ORAL
    2MG/ML
    2012-01-30
    200169
    LORAZEPAM
    RX
    No
    AA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 200169

    Looking for FDA Orange Book APPLICATION 200169 1

    19

    Hikma Pharmaceuticals, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is LORAZEPAM, with a corresponding application number 200169.

    Regulatory Information RX

    With a dosage strength 2MG/ML

    Dosage Form Route CONCENTRATE; ORAL

    Reference Listed Drug No

    Approved since 2012-01-30

    Therapeutic Equivalence (TE) Code AA

    Post Enquiry
    POST ENQUIRY